GlobeNewswire Inc | May 27, 2021 07:00AM EDT

May 27, 2021

SAN FRANCISCO, May 27, 2021 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN) today announced that Enrique Conterno, Chief Executive Officer, will participate in fireside chats at the following virtual healthcare conferences:

-- Jefferies Virtual Healthcare Conference on Friday, June 4, 2021 at 10:30 AM Eastern Time -- Goldman Sachs 42nd Annual Global Healthcare Conference on Thursday, June 10, 2021 at 3:00 PM Eastern Time

A live audio webcast will be available on the Events & Presentations section of the FibroGen Investor webpage at www.fibrogen.com. A replay will be available for approximately 30 days.

About FibroGen

FibroGen, Inc. is a biopharmaceutical company committed to discovering, developing, and commercializing a pipeline of first-in-class therapeutics. The Company applies its pioneering expertise in hypoxia-inducible factor (HIF) and connective tissue growth factor (CTGF) biology to advance innovative medicines for the treatment of unmet needs. The Company is currently developing and commercializing roxadustat, an oral small molecule inhibitor of HIF prolyl hydroxylase activity, for anemia associated with chronic kidney disease (CKD). Roxadustat is also in clinical development for anemia associated with myelodysplastic syndromes (MDS) and for chemotherapy-induced anemia (CIA). Pamrevlumab, an anti-CTGF human monoclonal antibody, is in clinical development for the treatment of locally advanced unresectable pancreatic cancer (LAPC), Duchenne muscular dystrophy (DMD), and idiopathic pulmonary fibrosis (IPF). For more information, please visit www.fibrogen.com.

Contact:FibroGen, Inc.

Investors:Michael Tung, M.D.Corporate Strategy / Investor Relationsmtung@fibrogen.com

Media:GCI HealthFibroGenMedia@gcihealth.com